Public screening for COVID‐19 in Wuhan, China and beware of the antibody positive in women and tumor patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Public screening for COVID‐19 in Wuhan, China and beware of the antibody positive in women and tumor patients

Published:2021-12-08 Issue: Volume: Page:
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J Med Virol

Author:

Shang Yufeng¹^ORCID,Liang Yuxing¹,Liu Tao²³^ORCID,Li Jingfeng⁴,Zhou Fuling¹^ORCID

Affiliation:

1. Department of Hematology Zhongnan Hospital of Wuhan University Wuhan China

2. Department of Urology Zhongnan Hospital of Wuhan University Wuhan China

3. Center for Evidence‐Based and Translational Medicine Zhongnan Hospital of Wuhan University Wuhan China

4. Department of Orthopedics Zhongnan Hospital of Wuhan University Wuhan China

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.27483

Reference13 articles.

1. Strategies to control COVID‐19 and future pandemics in Africa and around the globe;Fanidi A;Eur Heart J,2020

2. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus‐infected pneumonia in Wuhan, China;Wang D;JAMA,2020

3. LiuT ZengG TaoH et al.Low prevalence of IgG antibodies to SARS‐CoV‐2 in cancer patients with COVID‐19.Int J Cancer2020.[Online ahead of print]

4. Development and clinical application of a rapid IgM‐IgG combined antibody test for SARS‐CoV‐2 infection diagnosis;Li Z;J Med Virol,2020

5. False‐negative results of real‐time reverse‐transcriptase polymerase chain reaction for severe acute respiratory syndrome coronavirus 2: role of deep‐learning‐based CT diagnosis and insights from two cases;Li D;Korean J Radiol,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence and seroprevalence of COVID-19 infection among older people: A scoping review based on population-based studies in 2020-2022;2024-03-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3